Arctic Bioscience AS (OSL:ABS)
Norway · Delayed Price · Currency is NOK 2.790
-0.010 (-0.36%)
Aug 27, 2026, 9:50 AM CET
Arctic Bioscience AS Balance Sheet
Financials in millions NOK. Fiscal year is January - December.
Millions NOK. Fiscal year is Jan - Dec.
Assets
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 1.29 | 3.28 | 79.6 | 144.15 | 227.36 |
Cash & Short-Term Investments | 1.29 | 3.28 | 79.6 | 144.15 | 227.36 |
Cash Growth | -60.73% | -95.88% | -44.78% | -36.60% | 1704.45% |
Accounts Receivable | 10.21 | 14.57 | 9.57 | 13.48 | 7.7 |
Other Receivables | 8.2 | 11.05 | 11.19 | 5.24 | 3.34 |
Receivables | 18.4 | 25.62 | 20.76 | 18.71 | 11.05 |
Inventory | 29.62 | 28.99 | 32.79 | 35.46 | 28.53 |
Total Current Assets | 49.31 | 57.89 | 133.15 | 198.33 | 266.93 |
Property, Plant & Equipment | 22.81 | 24.47 | 26.44 | 22.33 | 15.99 |
Goodwill | 1.34 | 1.93 | 2.53 | - | - |
Other Intangible Assets | 1.42 | 1.59 | 1.78 | 2.14 | 2.33 |
Long-Term Deferred Charges | 209.77 | 193.87 | 136.35 | 104.9 | 56.22 |
Other Long-Term Assets | 0 | 0 | - | -0 | - |
Total Assets | 284.65 | 279.74 | 300.25 | 327.7 | 341.47 |
Liabilities
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Accounts Payable | 26.03 | 18.98 | 18.38 | 18.25 | 8.36 |
Accrued Expenses | 22.82 | 28.33 | 21.27 | 22.17 | 12.56 |
Short-Term Debt | - | 20.24 | - | - | - |
Current Portion of Long-Term Debt | 34.12 | - | - | - | 0 |
Other Current Liabilities | - | - | - | - | -0 |
Total Current Liabilities | 82.97 | 67.54 | 39.65 | 40.42 | 20.92 |
Long-Term Debt | 27.35 | - | - | - | - |
Long-Term Leases | 0.84 | 1.47 | 2.05 | - | - |
Total Liabilities | 111.17 | 69.01 | 41.69 | 40.42 | 20.92 |
Shareholders' Equity
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Common Stock | 2.7 | 2.54 | 2.54 | 2.44 | 2.43 |
Additional Paid-In Capital | 170.79 | 208.19 | 256.02 | 284.84 | 318.12 |
Shareholders' Equity | 173.49 | 210.73 | 258.56 | 287.28 | 320.55 |
Total Liabilities & Equity | 284.65 | 279.74 | 300.25 | 327.7 | 341.47 |
Additional Metrics
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Total Debt | 62.32 | 21.71 | 2.05 | - | 0 |
Net Cash (Debt) | -61.03 | -18.43 | 77.55 | 144.15 | 227.36 |
Net Cash Growth | - | - | -46.20% | -36.60% | 5385.57% |
Net Cash Per Share | -2.26 | -0.73 | 3.05 | 5.89 | 9.34 |
Filing Date Shares Outstanding | 26.96 | 25.37 | 25.37 | 24.46 | 24.3 |
Total Common Shares Outstanding | 26.96 | 25.37 | 25.37 | 24.46 | 24.3 |
Working Capital | -33.66 | -9.65 | 93.51 | 157.9 | 246.01 |
Book Value Per Share | 6.44 | 8.31 | 10.19 | 11.75 | 13.19 |
Tangible Book Value | 170.73 | 207.21 | 254.25 | 285.14 | 318.23 |
Tangible Book Value Per Share | 6.33 | 8.17 | 10.02 | 11.66 | 13.10 |
Buildings | 15.75 | - | - | 20.38 | 14.17 |
Machinery | 17.19 | - | - | 5.17 | 4.08 |